• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情期间在马来亚大学医学中心(UMMC)接受治疗的吸毒者(PWUD)的物质使用模式及相关因素。

The Pattern of Substance Use among People Who Use Drugs (PWUD) Receiving Treatment at University Malaya Medical Centre (UMMC) during the COVID-19 Pandemic and the Associated Factors.

作者信息

Yahaya Amir Zulhilmi Bin, Yee Anne, Sulaiman Ahmad Hatim

机构信息

Department of Psychological Medicine, University of Malaya, Kuala Lumpur 59100, Malaysia.

University Malaya Centre of Addiction Sciences (UMCAS), Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.

出版信息

Healthcare (Basel). 2022 Jul 23;10(8):1366. doi: 10.3390/healthcare10081366.

DOI:10.3390/healthcare10081366
PMID:35893189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9332428/
Abstract

There was a change in the pattern of substance usage among people who use substances during the COVID-19 pandemic period. This study aims to determine the effects of the COVID-19 pandemic on the pattern of substance usage among people who use drugs (PWUD) receiving treatment at the University Malaya Medical Centre (UMMC) as well as levels of anxiety and depression together with coping mechanisms and the factors affecting the pattern of substance use during COVID-19 pandemic period. A cross-sectional study was applied. The questionnaire used was the Mini-European Web Survey on Drugs (EWSD): COVID-19, Hospital Anxiety and Depression Scale (HADS), and Brief COPE Scale. In total, 130 PWUD were recruited. Of the participants, 36.2% of PWUD had not used/stopped the usage of illicit drugs/alcohol, 26.2% increased their usage, 20% decreased, and 14.6% used the same amount of illicit substances/alcohol during the COVID-19 pandemic period/restrictions. In addition, 28.5% of PWUD had an increased intention to seek professional support for drug counseling/treatment during the COVID-19 pandemic period. The prevalence anxiety and depression symptoms in PWUD according to HADS was 33% and 41.5%, respectively, with depression (p = 0.05) and isolation status (adjusted OR = 2.63, p < 0.05) being associated with an increase in alcohol/illicit substance use during the COVID-19 pandemic. PWUD who had increased their intention to seek professional support had significantly higher odds (adjusted OR = 4.42, p < 0.01) of reducing their alcohol/illicit substance use during the COVID-19 pandemic period. There were increased odds of maintaining alcohol/illicit substance usage among PWUD who practiced dysfunctional coping (adjusted OR = 3.87, p < 0.025) during the COVID-19 pandemic period. In conclusion, depression, isolation status, dysfunctional coping, and intention to seek professional support affected the pattern of alcohol/illicit substance use during the COVID-19 pandemic period. Strategies, substance rehabilitation/counseling, and proper mental health screening and the associated risk factors must be emphasized to prevent a further epidemic of substance use during the pandemic.

摘要

在2019冠状病毒病大流行期间,使用毒品的人群的物质使用模式发生了变化。本研究旨在确定2019冠状病毒病大流行对在马来亚大学医学中心(UMMC)接受治疗的吸毒者(PWUD)的物质使用模式、焦虑和抑郁水平、应对机制以及在2019冠状病毒病大流行期间影响物质使用模式的因素的影响。采用了横断面研究。所使用的问卷包括迷你欧洲药物网络调查(EWSD):2019冠状病毒病、医院焦虑和抑郁量表(HADS)以及简易应对量表。总共招募了130名吸毒者。在参与者中,36.2%的吸毒者在2019冠状病毒病大流行期间/限制措施实施期间未使用/停止使用非法药物/酒精,26.2%的人使用量增加,20%的人使用量减少,14.6%的人使用的非法物质/酒精量相同。此外,28.5%的吸毒者在2019冠状病毒病大流行期间寻求药物咨询/治疗专业支持的意愿增强。根据HADS,吸毒者中焦虑和抑郁症状的患病率分别为33%和41.5%,抑郁(p = 0.05)和隔离状态(调整后的OR = 2.63,p < 0.05)与2019冠状病毒病大流行期间酒精/非法物质使用增加有关。在2019冠状病毒病大流行期间寻求专业支持意愿增强的吸毒者减少酒精/非法物质使用的几率显著更高(调整后的OR = 4.42,p < 0.01)。在2019冠状病毒病大流行期间采用功能失调应对方式的吸毒者维持酒精/非法物质使用的几率增加(调整后的OR = 3.87,p < 0.025)。总之,抑郁、隔离状态、功能失调应对方式以及寻求专业支持的意愿在2019冠状病毒病大流行期间影响了酒精/非法物质的使用模式。必须强调相关策略、物质康复/咨询以及适当的心理健康筛查和相关风险因素,以防止在大流行期间物质使用的进一步流行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54f/9332428/299c875082de/healthcare-10-01366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54f/9332428/299c875082de/healthcare-10-01366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e54f/9332428/299c875082de/healthcare-10-01366-g001.jpg

相似文献

1
The Pattern of Substance Use among People Who Use Drugs (PWUD) Receiving Treatment at University Malaya Medical Centre (UMMC) during the COVID-19 Pandemic and the Associated Factors.新冠疫情期间在马来亚大学医学中心(UMMC)接受治疗的吸毒者(PWUD)的物质使用模式及相关因素。
Healthcare (Basel). 2022 Jul 23;10(8):1366. doi: 10.3390/healthcare10081366.
2
Substance use during the COVID-19 pandemic: What is really happening?新冠疫情期间的物质使用情况:实际发生了什么?
Psychiatriki. 2022 Mar 28;33(1):17-20. doi: 10.22365/jpsych.2022.072. Epub 2022 Feb 21.
3
The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study.COVID-19 大流行对格鲁吉亚非法药物供应、药物滥用者相关行为以及药物相关服务提供的影响:一项混合方法前瞻性队列研究的结果。
Harm Reduct J. 2022 Mar 9;19(1):25. doi: 10.1186/s12954-022-00601-z.
4
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada.2019冠状病毒病全球大流行期间吸毒者的物质供应和使用特征变化:加拿大的一项全国性定性评估
Int J Drug Policy. 2021 Jul;93:103237. doi: 10.1016/j.drugpo.2021.103237. Epub 2021 Apr 20.
5
COVID-19 and people who use drugs: Impact of the pandemic on general anxiety and depressive disorders among adults in Belgium.新型冠状病毒肺炎(COVID-19)与吸毒人群:大流行对比利时成年人一般焦虑症和抑郁症的影响。
J Affect Disord. 2021 Dec 1;295:946-953. doi: 10.1016/j.jad.2021.08.069. Epub 2021 Sep 9.
6
Assessing stigma: Health and social worker regard towards working with people using illicit drugs in Athens, Greece.评估污名化:希腊雅典的卫生和社会工作者对与使用非法药物者合作的看法。
Harm Reduct J. 2024 Sep 26;21(1):175. doi: 10.1186/s12954-024-01091-x.
7
Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.识别 COVID-19 大流行对吸毒者(PWUD)获得服务的影响:一项全国性定性研究。
J Subst Abuse Treat. 2021 Oct;129:108374. doi: 10.1016/j.jsat.2021.108374. Epub 2021 Mar 19.
8
Living with Drug Use and Addiction during the COVID-19 Pandemic.在 COVID-19 大流行期间应对药物使用和成瘾问题。
Subst Use Misuse. 2022;57(10):1504-1510. doi: 10.1080/10826084.2022.2086695. Epub 2022 Jul 5.
9
The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.COVID-19 对苏格兰减少伤害、药物使用治疗和康复服务获取的影响:一项定性研究。
BMC Public Health. 2022 Mar 15;22(1):500. doi: 10.1186/s12889-022-12873-y.
10
Alcohol and substance use in pregnancy during the COVID-19 pandemic.COVID-19 大流行期间孕妇的酒精和物质使用情况。
Drug Alcohol Depend. 2021 Aug 1;225:108760. doi: 10.1016/j.drugalcdep.2021.108760. Epub 2021 May 21.

引用本文的文献

1
Substance abuse among new patients attending main government hospitals in Malaysia from 2018-2021: A comparison between before and during COVID-19 pandemic.2018-2021 年期间,马来西亚主要政府医院新就诊患者的药物滥用情况:新冠疫情前后的比较。
PLoS One. 2024 Oct 24;19(10):e0309422. doi: 10.1371/journal.pone.0309422. eCollection 2024.
2
Exploring the Linkages Among Chronic Illness, Substance Use, and COVID-19 Infection in Adults Aged 50 Years and Older: Retrospective Cross-Sectional Analysis of National Representative Data.探讨 50 岁及以上成年人慢性病、物质使用与 COVID-19 感染之间的关联:基于全国代表性数据的回顾性横断面分析。
JMIR Aging. 2024 Oct 15;7:e63024. doi: 10.2196/63024.
3

本文引用的文献

1
Using Substances to Cope With the COVID-19 Pandemic: U.S. National Data at Age 19 Years.使用物质应对 COVID-19 大流行:19 岁时的美国全国数据。
J Adolesc Health. 2022 Feb;70(2):340-344. doi: 10.1016/j.jadohealth.2021.11.006. Epub 2021 Dec 13.
2
A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic.2020年新冠疫情期间非法药物、酒精的供应、价格、使用变化及相关并发症的全球调查
Front Psychiatry. 2021 Aug 6;12:646206. doi: 10.3389/fpsyt.2021.646206. eCollection 2021.
3
Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.
Trends in deaths following drug use in England before, during, and after the COVID-19 lockdowns.
英格兰在新冠疫情封锁前后药物使用致死趋势。
Front Public Health. 2023 Sep 29;11:1232593. doi: 10.3389/fpubh.2023.1232593. eCollection 2023.
2019冠状病毒病大流行期间物质使用及成瘾行为相关障碍防治专家共识
Gen Psychiatr. 2020 Jul 8;33(4):e100252. doi: 10.1136/gpsych-2020-100252. eCollection 2020.
4
Changing Patterns of Substance Use During the Coronavirus Pandemic: Self-Reported Use of Tobacco, Alcohol, Cannabis, and Other Drugs.新冠疫情期间物质使用模式的变化:自我报告的烟草、酒精、大麻及其他药物使用情况
Front Psychiatry. 2021 May 26;12:633551. doi: 10.3389/fpsyt.2021.633551. eCollection 2021.
5
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada.2019冠状病毒病全球大流行期间吸毒者的物质供应和使用特征变化:加拿大的一项全国性定性评估
Int J Drug Policy. 2021 Jul;93:103237. doi: 10.1016/j.drugpo.2021.103237. Epub 2021 Apr 20.
6
Changes in Drug Use Patterns during the COVID-19 Pandemic in Italy: Monitoring a Vulnerable Group by Hair Analysis.意大利 COVID-19 大流行期间药物使用模式的变化:通过毛发分析监测弱势群体。
Int J Environ Res Public Health. 2021 Feb 18;18(4):1967. doi: 10.3390/ijerph18041967.
7
Isolation, Solitude and Social Distancing for People Who Use Drugs: An Ethnographic Perspective.吸毒者的隔离、独处与社交距离:人种志视角
Front Psychiatry. 2021 Jan 13;11:623032. doi: 10.3389/fpsyt.2020.623032. eCollection 2020.
8
Cannabis Use During the COVID-19 Pandemic in Canada: A Repeated Cross-sectional Study.加拿大 COVID-19 大流行期间的大麻使用情况:一项重复横断面研究。
J Addict Med. 2021;15(6):484-490. doi: 10.1097/ADM.0000000000000798.
9
The Impact of Substance Use Disorder on COVID-19 Outcomes.物质使用障碍对 COVID-19 结局的影响。
Psychiatr Serv. 2021 May 1;72(5):578-581. doi: 10.1176/appi.ps.202000534. Epub 2020 Nov 3.
10
COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper.2019冠状病毒病与物质使用障碍:全面医疗应对建议。国际成瘾医学学会实践与政策兴趣小组立场文件
Basic Clin Neurosci. 2020 Mar-Apr;11(2):133-150. doi: 10.32598/bcn.11.covid19.1. Epub 2020 Apr 12.